Aemetis (NASDAQ:AMTX) Shares Cross Below 200-Day Moving Average – Here’s What Happened

Aemetis, Inc. (NASDAQ:AMTX)’s share price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $2.81 and traded as low as $1.95. Aemetis shares last traded at $2.00, with a volume of 688,056 shares changing hands.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on AMTX. HC Wainwright reaffirmed a “buy” rating and issued a $28.00 target price on shares of Aemetis in a report on Monday, December 23rd. StockNews.com raised shares of Aemetis to a “sell” rating in a report on Wednesday, February 5th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, Aemetis currently has an average rating of “Moderate Buy” and a consensus price target of $12.95.

Aemetis Trading Down 3.4 %

The company’s fifty day moving average price is $2.64 and its two-hundred day moving average price is $2.81. The firm has a market cap of $102.30 million, a P/E ratio of -0.88 and a beta of 1.44.

Aemetis (NASDAQ:AMTX) last announced its earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.47) by $0.09. The company had revenue of $81.44 million during the quarter, compared to the consensus estimate of $77.79 million. During the same period in the prior year, the firm posted ($0.59) earnings per share. On average, analysts predict that Aemetis, Inc. will post -2.07 EPS for the current fiscal year.

Institutional Trading of Aemetis

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Clear Harbor Asset Management LLC acquired a new position in Aemetis during the 4th quarter worth $44,000. Intech Investment Management LLC bought a new stake in shares of Aemetis during the fourth quarter worth $46,000. FMR LLC lifted its stake in shares of Aemetis by 68.2% during the third quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock valued at $52,000 after acquiring an additional 9,137 shares during the period. SG Americas Securities LLC bought a new position in Aemetis in the fourth quarter valued at about $87,000. Finally, Barclays PLC increased its position in Aemetis by 274.6% in the third quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock worth $109,000 after purchasing an additional 34,816 shares during the period. Institutional investors and hedge funds own 27.02% of the company’s stock.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.